[Antiphogistics and antirheumatics: pharmacologic testing, state and tendencies of development].
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002908:Chronic Disease; D000242:Cyclic AMP / Q000502:physiology; D006152:Cyclic GMP / Q000502:physiology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004837:Epinephrine / Q000494:pharmacology; D006634:Histamine H1 Antagonists; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D011448:Prostaglandin Antagonists; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012702:Serotonin Antagonists; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006634:Histamine H1 Antagonists; D011448:Prostaglandin Antagonists; D012702:Serotonin Antagonists; D000242:Cyclic AMP; D006152:Cyclic GMP; D004837:Epinephrine
Antiphlogistika und Antirheumatika: Pharmakologische Testung, Stand und Tendenzen der Entwicklung.